SEC Form 13F
| Report period | 2025-09-30 |
|---|---|
| Publicly available | 2025-11-13 |
| Reported value | $81,319,135 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BEAM THERAPEUTICS INC | BEAM | COM | $55,018,488 | 2,266,934 |
| LYELL IMMUNOPHARMA INC | LYEL | COM NEW | $16,371,804 | 1,008,116 |
| PRIME MEDICINE INC | PRME | COM | $9,928,843 | 1,792,210 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.